Pomegranate constituents inhibit angiogenesis via downregulation of vascular endothelial growth factor (VEGF) in human umbilical vein endothelial and MCF-7 breast cancer cell lines [44], thereby hampering the tumor growth. This evidence concerns the gene VEGFA and neoplasm.